No photo of Geoffrey Kline

View Scopus Profile

Geoffrey Kline, DO, PhD

  • 9 Citations
  • 1 h-Index
1996 …2024
If you made any changes in Pure, your changes will be visible here soon.

Projects 2013 2024

Filter
Active
Active

A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF).

Kline, G.

Boehringer Ingelheim International GmbH

25/04/17 → 24/04/21

Project: Research

A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).

Kline, G.

Boehringer Ingelheim International GmbH

25/04/17 → 24/04/21

Project: Research

PROMINENT- PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETES

Kline, G.

Kowa Research Institute, Inc.

31/03/17 → 31/03/21

Project: Research

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (ETC-I 002) on the Occurrence of Major Cardiovascular Events in Patients with, or at High Risk For,Cardiovascular Disease Who Are Statin Intolerant

Kline, G.

Esperion Therapeutics, Inc.

13/02/17 → 13/02/21

Project: Research

A Long-term Outcomes Study to Assess Statin Residual Risk Reduction with EpaNova High Cardiovascular Risk Patients witgh Hypertriglyceridemia (STRENGTH)

Kline, G.

Astra Zeneca

8/06/15 → 30/06/24

Project: Research

A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Long-term Safety and Tolerability of PF-04950615 in Subjects with Primary Hyperlipidemia or Mixed Dyslipdemia at Risk of Cardiovascular Events

Kline, G.

Pfizer, Inc.

17/03/15 → 31/03/20

Project: Research

A Readomized. Double-blind, Placebo-controlled,Parallel-group Studfy to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patgients Who Have Recently Experienced an Acute Coronary Syndrome

Kline, G.

Sanofi Pasteur, Inc.

31/01/13 → 30/01/20

Project: Research